SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Not all strokes are equally devastating, and new research shows that certain health risks don’t just increase your chances of ...

Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.

A cardiologist has shared six warning signs of heart troubles that should never be ignored after TV presenter Emma Willis, 49 ...

“It was an experience that dramatically improved my life,” said Mike Prescott of Kenosha, who retired a couple of years ago ...

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...

When it comes to a simple, accessible, beneficial form of exercise, walking is hard to top – and a new study suggests that ...

Here’s a reason to celebrate: new research suggests this boozy beverage can have protective benefits to your heart.

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...